From the same participant

1. Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia treated with the antipsychotic compounds clozapine or olanzapine?

   Project: Types of projects › Project

2. Kan behandling med psilocybin reducere indtaget af alkohol hos patienter med diagnosen alkoholafhængighed?

   Project: Types of projects › Project

3. Does a ketogenic dietary supplement reduce alcohol withdrawal symptoms in humans?

   Project: Types of projects › Project

4. Virtual Reality-assisteret eksponeringsterapi til patienter med alkoholafhængighed: Et randomiseret klinisk studie

   Project: Types of projects › Project

5. Does Glucagon-like Peptide 1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence?

   Project: Types of projects › Project

6. Glycine reuptake inhibitors as a novel treatment strategy in alcohol abuse disorders

   Project: Types of projects › Project

7. Gene x environment interactions in Schizophrenia at the level of genetic polymorphisms and environmental risk factors

   Project: Types of projects › Project

8. The role of muscarinic receptors in sucrose intake.

   Project: Types of projects › Project

9. Localization of the circannual clock in the European hamster. An anterograde in vivo neuronal tracing study

   Project: Types of projects › Project

10. Den muskarine M4 receptors rolle i regulering af dopaminerg neurotransmission –et nyt mål for medicinsk behandling af skizofreni?

    Project: Types of projects › Project